Page last updated: 2024-10-30

mesalamine and Cronkhite-Canada Syndrome

mesalamine has been researched along with Cronkhite-Canada Syndrome in 4 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Cronkhite-Canada Syndrome: A nonfamilial polyposis syndrome that is characterized by the presence of diffuse gastrointestinal polyposis, DIARRHEA, and PROTEIN-LOSING ENTEROPATHY. It was first reported by Cronkhite and Canada in 1955.

Research Excerpts

ExcerptRelevanceReference
"The prednisolone dose was reduced to 7."1.51Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine. ( Drebber, U; Kaufmann, T; Kütting, F; Mertens, J; Nierhoff, D; Schulte, S; Steffen, HM; Töx, U, 2019)
"Cronkhite-Canada syndrome is an acquired inflammatory polyposis syndrome in which alopecia, onychomadesis and hyperpigmentation occur concurrently with gastrointestinal symptoms."1.46Alopecia areata incognita in Cronkhite-Canada syndrome. ( Carton, J; Grabczynska, S; Kubba, F; Ong, S; Osborn, M; Rodriguez-Garcia, C; Stefanato, CM; Walters, J, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Kidoguchi, K1
Kubota, Y1
Fujimoto, S1
Sakata, Y1
Kizuka-Sano, H1
Yamaguchi, K1
Ureshino, H1
Katsuya, H1
Ando, T1
Esaki, M1
Kimura, S1
Schulte, S1
Kütting, F1
Mertens, J1
Kaufmann, T1
Drebber, U1
Nierhoff, D1
Töx, U1
Steffen, HM1
Ong, S1
Rodriguez-Garcia, C1
Grabczynska, S1
Carton, J1
Osborn, M1
Walters, J1
Kubba, F1
Stefanato, CM1
Zimmer, V1
Grünhage, F1
Jüngling, B1
Kraemer, J1
Bohle, RM1
Lammert, F1

Other Studies

4 other studies available for mesalamine and Cronkhite-Canada Syndrome

ArticleYear
Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
    Internal medicine (Tokyo, Japan), 2021, Volume: 60, Issue:10

    Topics: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Histocompatibility Antigens Class I; Humans; Intestina

2021
Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine.
    BMC gastroenterology, 2019, Feb-27, Volume: 19, Issue:1

    Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diarrhea; Drug Adm

2019
Alopecia areata incognita in Cronkhite-Canada syndrome.
    The British journal of dermatology, 2017, Volume: 177, Issue:2

    Topics: Alopecia Areata; Anti-Inflammatory Agents, Non-Steroidal; Female; Glucocorticoids; Humans; Intestina

2017
A stomach carpeted red.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011, Volume: 43, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Gastroscopy; Glucocorticoids; Humans; Intesti

2011